The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp

Clinical Endocrinology

Volumn 47, Issue 6, 1997, Pages 685-691

  Russell Jones, D L ^a,c   Umpleby, A M ^a   Shojaee Moradie, F ^a   Boroujerdi, M A ^a   Jones, R H ^a   Baxter, R C ^b   Sonksen P H ^a  

^a UMDS   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0031455740     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.3161133.x     Document Type: Article

References (38)

1. Baxter, R.C. (1990) Circulating levels and molecular distribution of the acid-labile subunit of the high molecular weight insulin-like growth factor-binding protein. Journal of Clinical Endocrinology & Metabolism, 70, 1347-1353.
2. Baxter, R.C., Hizuka, N., Takano, K., Holman, S.R. & Asakawa, K. (1993) Responses of insulin-like growth factor binding protein-1 (IGFBP-1) and the IGFBP-3 complex to administration of insulin-like growth factor-1. Acta Endocrinologica, 128, 101-108.
3. Baxter, R.C. & Martin, J.L. (1986) Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. Journal of Clinical Investigation, 78, 1504-1512.
4. Baxter, R.C., Martin, J.L. & Wood, M.H. (1987) Two immunoreactive binding proteins for insulin-like growth factors in human amniotic fluid; relationship to fetal maturity. Journal of Clinical Endocrinology & Metabolism, 6, 423-431.
5. Boulware, S.D., Tambolane, W.V., Matthews, L.S. & Sherwin, R.S. (1992) Diverse effects of IGF-I on glucose and amino acid metabolism. American Journal of Physiology, 262(25), E130-E133
6. Brismar, K., Gutniak, M., Povoa, G., Werner, S. & Hall, K. (1988) Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. Journal of Endocrinological Investigation, 11 599-602.
7. Conover, C.A. (1990) Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-1 in cultured bovine fibroblasts. Endocrinology, 126, 139-145.
8. Copeland, C.C. & Nair, K.S. (1994) Recombinant human IGF-1 increases forearm blood flow. Journal of Clinical Endocrinology & Metabolism, 79, 230-232.
9. Czerwinski, S.M., Novakofski, J. & Betchel, P.J. (1993) Is IGF gene expression modulated during cardiac hypertrophy? Medical Science Sports Exercise, 25, 4: 495-500.
10. DeFronzo, R.A., Felig, P., Ferrannini, E. & Wahren, J. (1980) Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. American Journal of Physiology, 238, E421-E427.
11. DeFronzo, R.A., Sherwin, R.S., Dillingham, M., Hendler, R. Tamborlane, W.V. & Felig, P. (1978) Influence of basal insulin and glucagon secretion on potassium and sodium metabolism Journal of Clinical Investigation, 61, 472-479.
12. Guler, H.P., Eckardt, K.U., Zapf, J., Bauer, C. & Froesch, E.R. (1989) IGF-I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinologica, 121, 101-106.
13. Guler, H.P., Zapf, J. & Froesch, E.R. (1987) Short-term metabolic effects of recombinant human IGF-I in healthy adults. New England Journal of Medicine, 317, 137-140.
14. Guse, A.M., Kiess, W., Funk, B., Kessler, U., Berg, I. & Gerken, G. (1992) Identification and characterization of IGF receptors on adult rat cardiac myocytes: Linkage to inositol, 1,4,5-triphosphate formation. Endocrinology, 130, 145-151.
15. Hintz, R.L., Liu, F., Rosenfeld, R.G. & Kemp, S.F. (1981) Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. Journal of Clinical Endocrinology & Metabolism, 53, 100-104.
16. Hodgkinson, S.C., Davis, S.R., Henderson, H.V. & Gluckman, P.D. (1987) Metabolic clearance rate of insulin-like growth factor-1 in fec and starved sheep. Journal of Endocrinology, 115, 233-240.
17. Kerr, D., Tamborlane, W.V., Rife, F. & Sherwin, R.S. (1993) Effects of IGF-I on the responses to and recognition of hypoglycaemia in humans. Journal of Clinical Investigation, 91, 141-143.
18. Lewitt, M.S. & Baxter, R.C. (1990) Inhibitors of glucose uptake stimulate the production of insulin-like growth factor-binding protein (IGFBP-1) by fetal liver. Endocrinology, 126, 1 527-533.
19. Mauras, N., Horber, F. & Haymond, M. (1992) Low dose recombinant human IGF-I fails to affect protein anabolism but inhibits islet cell secretion in humans. Journal of Clinical Endocrinology & Metabolism, 75, 1192-1197.
20. Miell, J.P., Taylor, A.M., Jones, J., Buchanan, C.R., Rennes, J., Sherwood, R., Leicester & Ross, R. (1992) Administration of human recombinant IGF-I to patients following major gastrointestinal surgery. Clinical Endocrinology, 37, 542-551.
21. Prosser, C.G., Fleet, I.R., Corps, A.N., Froersh, E.R. & Heap, R.B. (1990) Increase in milk secretion and mammary blood flow by intraarterial infusion of IGF-I into the mammary gland of the goat. Journal of Endocrinology, 126, 437-145.
22. Rechler, M.M. & Brown, A.L. (1992) Insulin-like growth factor binding proteins: Gene structure and Expression. Growth Regulation, 2, 55-68.
23. Rossetti, L., Klein-Robbenhaar, G., Giebisch, G., Smith, D. & DeFronzo, R. (1987) Efect of insulin on renal potassium metabolism. American Journal of Physiology, 252, F60-F64.
24. Russell-Jones, D.L., Umpleby, A.M., Hennessy, T.R., Bowes, S.B., Hopkins, K.D., Jackson, N., Kelly, J., Thomason, M., Shojaee-Moradie, F., Jones, R.H. & Sonksen, P.H. (1995) A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and cardiovascular system. European Journal of Clinical Investigation, 25, 403-411.
25. Russell-Jones, D.L., Umpleby, A.M., Hennessy, T.R., Bowes, S.B., Shojaee-Moradie, F., Hopkins, K.D., Jackson, N.C., Kelly, J.M., Jones, R.H., Sonksen, P.H. (1994) Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. American Journal of Physiology 267, E591-E598.
26. Scott, A.R., Bennett, T. & Macdonald, I.A. (1988) Effects of hyperinsulinaemia on the cardiovascular responses to graded hypovolaemia in normal and diabetic subjects. Clinical Science, 75, 85-92.
27. Smedes, F., Kraak, J.C. & Poppe, H. (1982) A simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. Journal of Chromatography, 231, 25-39.
28. Sönksen, P.H. (1976) Double antibody technique for the simultaneous assay of insulin and growth hormone. In Hormones in human blood: detection and assay. (ed. H. Antoniades), pp. 176-199. Harvard University Press, Cambridge, MA.
29. Suikkari, A.M., Koivisto, V.A., Rutanen, E.M., Yki-Järninen, H., Karonen, S.L. & Seppälä, M. (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. Journal of Clinical Endocrinology & Metabolism, 66, 266-272.
30. Svensson, S., Berglin, E., Ekroth, R., Milocco, I., Nilsson, F. & William-Olsson, G. (1984) Haemodynamic effects of a single large dose of insulin in open heart surgery. Cardiovascular Research, 18(11), 697-701.
31. Teale, J.D. & Marks, V. (1990) Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumor hypoglycaemia. Clinical Endocrinology, 33, 87-98.
32. Tonshoff, B., Kaskel, F.J. & Moore, L.C. (1994) Differential effects of rhIGF-I on renal microvasculature in the rat juxtamedullary nephron preparation. Growth Regulation, 4, 107 (abs II235).
33. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C. & Goligorsky, M.S. (1994) Direct demonstration of IGF-I induced nitric oxide production by endothelial cells. Kidney International, 45, 598-604.
34. Turkalj, I., Keller, U., Ninnis, R., Vosmer, S. & Stauffacher, W. (1992) Effect of increasing doses of recombinant human IGF-I on glucose, lipid, and leucine metabolism in man. Journal of Clinical Endocrinology & Metabolism, 75, 1186-1191.
35. Umpleby, A.M., Shojaee-Moradie, F., Thomason, M.J., Kelly, J.M., Skottner, A., Sönksen, P.H. & Jones, R.H. (1994) Effects of insulin-like growth factor I (IGF-I), insulin and combined IGF-I and insulin infusions on protein metabolism in dogs. European Journal of Clinical Investigation, 24, 4337-4344.
36. Yeoh, S.I. & Baxter, R.C. (1988) Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinologica (Copenh), 119, 465-473.
37. Zapf, J., Hauri, C., Waldvogel, M., Futo, E., Hasler, H., Binz, K., Guler, H.P., Schmid, C. & Froesc, E.R. (1989) Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proceedings of the National Academy of Science USA, 86, 3813-3817.
38. Zapf, J., Schmid, C., Guler, H.P., Waldvogel, M., Hauri, C., Futo, E., Hossenlopp, P., Binoux, M. & Froesch, E.R. (1990) Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF treatment of healthy adults and in patients with extrapancreatic tumour hypoglycaemia. Journal of Clinical Investigation, 86, 952-961.